相关实验视频
Updated: May 5, 2026

05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
4.0K
基于亡策略的纳米输送系统的进步,用于增强类风湿性关节炎治疗
Zongquan Zhang1, Yilin Liu1, Xiaoya Liang1
1Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China.
Acta biomaterialia
|March 28, 2025
概括
向纳米输送系统 (NDS) 通过诱导恶性细胞的亡来提供一种新的类风湿性关节炎 (RA) 治疗方法. 在RA治疗中,这些先进的NDS显示出降低炎症和预防骨质侵蚀的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
- 类风湿病学 类风湿病学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,其特征是关节炎和骨质侵蚀.
- 关节炎的发病包括过度激活的免疫细胞 (巨细胞,中性粒细胞),纤维细胞样同胞细胞和骨质细胞,破坏关节的微环境.
- 传统的RA疗法由于毒性和副作用而面临限制.
研究的目的:
- 审查针对性纳米输送系统 (NDS) 的研究进展,利用类风湿性关节炎 (RA) 治疗的亡策略.
- 讨论NDSs在各种RA相关细胞中诱导亡的优势.
- 探索结合多细胞亡诱导以增强RA治疗的潜力.
主要方法:
- 对针对性NDS和RA的亡策略的现有文献进行全面审查.
- 对旨在针对类型特定的关节炎微环境 (RAM) 中特定细胞类型的NDS进行分析.
- 讨论前临床研究,证明诱导亡的NDSs的疗效.
主要成果:
- 向的NDS可以特别诱导RA相关的恶性细胞的亡,减少炎症性细胞因子的产生和致病细胞的增殖.
- 接体修饰的NDS利用RA细胞上的受体过度表达,以向传递和诱导亡.
- 结合多种细胞类型的亡诱导,为全面的RA管理提供了一个有希望的策略.
结论:
- 基于亡策略的向性NDS代表了RA治疗的重大进步.
- 这些系统通过选择性地消除恶性细胞和减轻关节损伤,提高了治疗效果.
- 对多点亡NDS的进一步研究可能会导致对RA和其他慢性炎症疾病的更有效的治疗方法.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165

